BOT — Botanix Pharmaceuticals Balance Sheet
0.000.00%
- AU$284.36m
- AU$242.68m
- AU$5.76m
Annual balance sheet for Botanix Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 21.6 | 7.29 | 10.3 | 79.3 | 65 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.045 | 0.141 | 0.489 | 2.28 | 3.2 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 21.6 | 10.5 | 14 | 82.9 | 99.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.278 | 0.179 | 0.065 | 0.072 | 1.38 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 22 | 14 | 24.8 | 112 | 129 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.04 | 5.89 | 1.89 | 3.73 | 24.9 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.15 | 5.89 | 1.89 | 3.73 | 47.8 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 20.8 | 8.15 | 23 | 109 | 81.3 |
| Total Liabilities & Shareholders' Equity | 22 | 14 | 24.8 | 112 | 129 |
| Total Common Shares Outstanding |